|Articles|January 7, 2016
Nimblify’s Participant Payment System Makes Its Debut
Participant Payments provides clinical research sites the choice to pay participants via reloadable debit card, direct deposit or check.
Advertisement
Nimblify, Inc., a clinical trials technology company and wholly owned subsidiary of Forte Research Systems, has launched its first offering, a participant-centered payment system. Participant Payments provides clinical research sites the choice to pay participants via reloadable debit card, direct deposit or check, without additional work for the site. In addition to an improved patient experience, Participant Payments provides coordinators the ability to set clear expectations with participants with the help of protocol-specific guidelines, including pre-approved stipend amounts and maximums for hotel and parking reimbursements.
Read the full release .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How Sponsors Can Modernize Tools to Support Physicians
September 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief Episode 7: Veeva and Merck Trial Efficiency, DCT Barriers, and Glucose Monitoring Strategies
2
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
3
Beyond the Algorithm: How Human-Centered AI Design Can Drive Clinical Trial Success
4
Summit Therapeutics’ Bispecific Antibody Shows Positive Survival Trend in Non-Small Cell Lung Cancer
5